Publication details

Ranibizumab (Lucentis) pro terapii věkem podmíněné makulární degenerace

Title in English Ranibizumab (Lucentis) for treatment of age related macular degeneration
Authors

KOLÁŘ Petr

Year of publication 2008
Type Article in Proceedings
Conference Praktické lékárenství (Astrakta II. kongresu praktického lékárenství)
MU Faculty or unit

Faculty of Medicine

Citation
Web pořadatel
Field ORL, ophthalmology, stomatology
Keywords ranibizumab; age related macular degeneration; vascular endothelial growth factor; intraocular injection into vitreous humour
Description Ranibizumab is a fragment of recombinant humanized monoclonar antibody against vascular growth factor. It is used for treatment of wet age related macular degeneration.

You are running an old browser version. We recommend updating your browser to its latest version.

More info